Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP189587.RA916rMoGuyEU9JutAcOCLvY6sc_j6gWhdmZEfCIyekRA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP189587.RA916rMoGuyEU9JutAcOCLvY6sc_j6gWhdmZEfCIyekRA130_assertion type Assertion NP189587.RA916rMoGuyEU9JutAcOCLvY6sc_j6gWhdmZEfCIyekRA130_head.
- NP189587.RA916rMoGuyEU9JutAcOCLvY6sc_j6gWhdmZEfCIyekRA130_assertion description "[The MAL gene, which has been shown to confer resistance to cancer therapy, was most highly overexpressed in short-term survivors (3-fold compared with long-term survivors, and 29-fold compared with early-stage cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP189587.RA916rMoGuyEU9JutAcOCLvY6sc_j6gWhdmZEfCIyekRA130_provenance.
- NP189587.RA916rMoGuyEU9JutAcOCLvY6sc_j6gWhdmZEfCIyekRA130_assertion evidence source_evidence_literature NP189587.RA916rMoGuyEU9JutAcOCLvY6sc_j6gWhdmZEfCIyekRA130_provenance.
- NP189587.RA916rMoGuyEU9JutAcOCLvY6sc_j6gWhdmZEfCIyekRA130_assertion SIO_000772 15897565 NP189587.RA916rMoGuyEU9JutAcOCLvY6sc_j6gWhdmZEfCIyekRA130_provenance.
- NP189587.RA916rMoGuyEU9JutAcOCLvY6sc_j6gWhdmZEfCIyekRA130_assertion wasDerivedFrom befree-20140225 NP189587.RA916rMoGuyEU9JutAcOCLvY6sc_j6gWhdmZEfCIyekRA130_provenance.
- NP189587.RA916rMoGuyEU9JutAcOCLvY6sc_j6gWhdmZEfCIyekRA130_assertion wasGeneratedBy ECO_0000203 NP189587.RA916rMoGuyEU9JutAcOCLvY6sc_j6gWhdmZEfCIyekRA130_provenance.